Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
68
RVMD Quote, Financials, Valuation and Earnings
Last price:
$81.20
Seasonality move
:
-4.35%
Day range:
$80.01 - $81.97
52-week range:
$29.17 - $81.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
9.83x
Volume:
1.4M
Avg. volume:
2.5M
1-year change:
82.9%
Market cap:
$15.7B
Revenue:
--
EPS (TTM):
-$5.18
Earnings Data
Next earnings date for RVMD
Feb 25
2026
Most recent earnings per share
-$1.61
Missed by $0.20
(Nov 5/2025)
Consensus Estimate
-$1.41
(Nov 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RVMD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 | $2.7M | -- | -- | -$1.60 | -- |
| 11/05/2025 | Q3 | $1.5M | -- | -$1.61 | -$1.41 | -$0.20 |
| 08/06/2025 | Q2 | $27.5M | -- | -$1.31 | -$1.12 | -$0.19 |
| 05/07/2025 | Q1 | -- | -- | -$1.13 | -$1.06 | -$0.08 |
| 02/26/2025 | Q4 | $346.2K | -- | -$1.12 | -$0.96 | -$0.16 |
| 11/06/2024 | Q3 | $346.2K | -- | -$0.94 | -$0.88 | -$0.06 |
| 08/07/2024 | Q2 | $807.7K | -- | -$0.81 | -$0.76 | -$0.04 |
| 05/08/2024 | Q1 | $674.2K | -- | -$0.70 | -$0.72 | $0.01 |
| 02/26/2024 | Q4 | $1.2M | $742K | -$1.14 | -$0.88 | -$0.27 |
| 11/06/2023 | Q3 | $857.1K | -- | -$0.99 | -$1.00 | $0.01 |
| 08/08/2023 | Q2 | -- | $3.8M | -$0.92 | -- | -- |
| 05/08/2023 | Q1 | -- | $7M | -$0.72 | -- | -- |
| 02/27/2023 | Q4 | -- | $15.3M | -$0.63 | -- | -- |
| 11/07/2022 | Q3 | -- | $3.4M | -$0.87 | -- | -- |
| 08/09/2022 | Q2 | -- | $9.1M | -$0.82 | -- | -- |
| 05/09/2022 | Q1 | -- | $7.6M | -$0.78 | -- | -- |
| 02/28/2022 | Q4 | -- | $9.5M | -$0.71 | -- | -- |
| 11/10/2021 | Q3 | -- | $1.1M | -$0.72 | -- | -- |
| 08/11/2021 | Q2 | -- | $8.7M | -$0.60 | -- | -- |
| 05/10/2021 | Q1 | -- | $10.1M | -$0.53 | -- | -- |
| 03/02/2021 | Q4 | -- | $8.8M | -$0.51 | -- | -- |
| 11/12/2020 | Q3 | -- | $12.7M | -$0.42 | -- | -- |
| 08/10/2020 | Q2 | -- | $10M | -$0.46 | -- | -- |
| 05/14/2020 | Q1 | -- | $11.5M | -$0.37 | -- | -- |
| 12/31/2019 | Q4 | -- | $12.1M | -$0.32 | -- | -- |
| 09/30/2019 | Q3 | -- | $12.5M | -$0.30 | -- | -- |
| 06/30/2019 | Q2 | -- | $12.3M | -$0.23 | -- | -- |
| 03/31/2019 | Q1 | -- | $13.2M | -$0.23 | -- | -- |
| 12/31/2018 | Q4 | -- | $10.3M | -$0.23 | -- | -- |
Revolution Medicines, Inc. Earnings Questions
-
How Much did Revolution Medicines, Inc. Generate in Revenue Last Quarter?
Revolution Medicines, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Revolution Medicines, Inc. Beat Earnings Last Quarter?
Revolution Medicines, Inc. announced earnings per share of -$1.61 which represents a miss of analyst forecast a -$1.41 per share.
-
Is Revolution Medicines, Inc. Profitable?
Revolution Medicines, Inc. reported -$4.3M that represents -$0.02 per share over the last quarter.
-
What is the Analyst Consensus for Revolution Medicines, Inc. EPS Next Year?
Revolution Medicines, Inc.'s earnings are forecast to decrease from -$3.58 per share to -$3.43 per share next year representing a decrease of -54.88%.
-
When is Revolution Medicines, Inc.'s Earnings Date?
Revolution Medicines, Inc.'s next earnings date is February 25, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
